Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies

Molecular and Cellular Biology

Volumn 18, Issue 3, 1998, Pages 1611-1621

  Gire, Veronique ^a   Wynford Thomas, David ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; MONOCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; CELL AGING; CELL CYCLE S PHASE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA SYNTHESIS; FIBROBLAST CULTURE; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROINJECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031935827     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.3.1611     Document Type: Article

References (65)

1. Abarzua, P., J. E. LoSardo, M. L. Gubler, and A. Neri. 1995. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53. Cancer Res. 55:3490-3494.
2. Alcorta, D. A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barrett. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742-13747.
3. Atadja, P., H. Wong, I. Garkaavtsev, C. Geillette, and K. Riabowol. 1995. Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. USA 92:8348-8352.
4. Bacchetti, S. 1996. Telomere dynamics and telomerase activity in cell senescence and cancer. Cell Dev. Biol. 7:31-39.
5. Banks, L., G. Matlashewski, and L. Crawford. 1986. Isolation of human p53 specific monoclonal antibodies and their use in the study of human p53 expression. Eur. J. Biochem. 159:529-534.
6. Blaydes, J. P., V. Gire, M. Rowson, and D. Wynford-Thomas. 1997. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2. Oncogene 14:1859-1868.
7. Bond, J. A., F. S. Wyllie, and D. Wynford-Thomas. 1994. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9:1885-1889.
8. Bond, J. A., J. P. Blaydes, J. Rowson, M. F. Haughton, J. R. Smith, D. Wynford-Thomas, and F. S. Wyllie. 1995. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res. 55:2404-2409.
9. Bond, J. A., M. Haughton, J. Blaydes, D. Wynford-Thomas, and F. S. Wyllie. 1996. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13:2097-2104.
10. Bond, J. A., M. Ivan, F. Wyllie, and D. Wynford-Thomas. 1997. Control of proliferative lifespan by tumour suppressor genes (TSGs): cell-type diversity in senescence checkpoints, abstr. 79. In Abstracts of the Cancer Research Campaign Beatson International Cancer Conference, Glasgow, Scotland.
11. Böttger, V., A. Böttger, S. F. Howard, S. M. Picksley, P. Chène, C. Garcia-Echeverria, H.-K. Hochkeppel, and D. P. Lane. 1996. Identification of novel mdm2 binding peptides by phage display. Oncogene 13:2141-2147.
12. Bowman, P. D., R. L. Meek, and C. W. Daniel. 1975. Aging of human fibroblasts in vitro. Exp. Cell Res. 93:184-190.
13. CIP1/WAF1 gene in normal diploid human fibroblasts. Science 177:831-834.
14. Bryan, T. M., and R. R. Reddel. 1994. SV40-induced immortalization of human cells. Crit. Rev. Oncogenesis 5:331-357.
15. Campisi, J. 1996. Replicative senescence: an old lives' tale? Cell 84:497-500.
16. Cristofalo, V. J., and R. J. Pignolo. 1993. Replicative senescence of human fibroblast-like cells in culture. Phys. Rev. 73:617-638.
17. Deppert, W., M. Haug, and T. Steinmayer. 1987. Modulation of p53 protein expression during cellular transformation with simian virus 40. Mol. Cell. Biol. 7:4453-4463.
18. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, M. Peacocke, and J. Campisi. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
19. Edington, K. G., O. P. Loughran, I. J. Berry, and E. K. Parkinson. 1995. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol. Carcinogen. 13:254-265.
20. El-Deiry, W. S., T. Tokino, V. E. Velculescu, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumour suppression. Cell 75:817-825.
21. Gire, V., C. Hall-Jackson, H. Paterson, C. J. Marshall, and D. Wynford-Thomas. 1996. Induction of DNA synthesis in human primary thyroid epithelial cells by microinjection of mutant p21 ras oncoprotein. J. Endocrinol. Invest. 19:5.
22. Gluzman, Y., J. F. Sambrook, and R. J. Frisque. 1980. Expression of early genes of origin-defective mutants of simian virus 40. Proc. Natl. Acad. Sci. USA 77:3898-3902.
23. Goldstein, S. 1990. Replicative senescence: the human fibroblast comes of age. Science 249:1129-1133.
24. Gorman, S. D., and V. J. Cristofalo. 1985. Reinitiation of cellular DNA synthesis in BrdU-selected nondividing senescent WI-38 cells by simian virus 40 infection. J. Cell. Phys. 125:122-126.
25. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16:859-867.
26. Hara, E., J. A. Uzman, G. P. Dimri, J. O. Nehlin, A. Testori, and J. Campisi. 1996. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts. Dev. Genet. 18:161-172.
27. Harlow, E., L. V. Crawford, D. C. Pim, and N. W. Williamsen. 1981. Monoclonal antibodies specific for simian virus 40 tumour antigens. J. Virol. 39: 861-869.
28. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
29. Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:614-636.
30. Hess, R. D., and G. Brandner. 1997. DNA-damage-inducible p53 activity in SV40-transformed cells. Oncogene 15:2501-2504.
31. 1 arrest. Proc. Natl. Acad. Sci. USA 93:4827-4832.
32. Hupp, T. R., and D. P. Lane. 1994. Allosteric activation of latent p53 tetramers. Curr. Biol. 4:865-875.
33. Hupp, T. R., A. Sparks, and D. P. Lane. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83:237-245.
34. Ide, T., Y. Tsuji, S. Ishibashi, and Y. Mitsuf. 1983. Reinitiation of host DNA synthesis in senescent human diploid cells by infection with simian virus 40. Exp. Cell Res. 143:343-349.
35. Kubbutat, M. H. G., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
36. Legros, Y., C. Lafon, and T. Soussi. 1994. Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein. Oncogene 9:2071-2076.
37. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
38. Lin, J., A. K. Teresky, and A. J. Levine. 1995. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 10:2387-2390.
39. Macieira-Coelho, A., and F. Taboury. 1982. A re-evaluation of the changes in proliferation in human fibroblasts during ageing in vitro. Cell Tissue Kinet. 15:213-224.
40. WAF1/Cip1/Sdi1-related protein, correlates with measurement of the finite proliferative potential of rodent embryo fibroblasts. Proc. Natl. Acad. Sci. USA 94:151-156.
41. Medcalf, A. S. C., A. J. P. Klein-Szanto, and V. J. Cristofalo. 1996. Expression of p21 is not required for senescence of human fibroblasts. Cancer Res. 56:4582-4585.
42. Michael-Michalovitz, D., D. Eliyahu, and M. Oren. 1986. Overproduction of protein p53 contributes to simian virus 40-mediated transformation. Mol. Cell. Biol. 6:3531-3536.
43. Midgley, C. A., C. J. Fisher, J. Bartek, B. Vojtesek, D. P. Lane, and D. M. Barnes. 1992. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in E. Coli. J. Cell Sci. 101:183.
44. Mundt, M., T. Hupp, M. Frische, C. Merkle, S. Hansen, D. Lane, and B. Groner. 1997. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene 15:237-244.
45. Nakanishi, M., G. R. Adami, R. S. Robetorye, A. Noda, S. F. Venable, D. Dimitrov, O. M. Pereira-Smith, and J. R. Smith. 1995. Exit from G0 and entry into the cell cycle of cells expressing p21 Sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA 92:4352-4356.
46. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
47. Sdi/Cip1/Waf1/mda-6 and expression of other cyclin-dependent kinase inhibitors in senescent human cells. Mol. Cell. Differ. 4:113-126.
48. Rubelj, I., and O. M. Pereira-Smith. 1994. SV40-transformed human cells in crisis exhibit changes that occur in normal cellular senescence. Exp. Cell Res. 211:82-89.
49. Sakamoto, K., T. Howard, V. Ogryzko, N.-Z. Xu, C. C. Corsico, D. H. Jones, and B. Howard. 1993. Relative mitogenic activities of wild-type and retinoblastoma binding-defective SV40 T antigens in serum-deprived and senescent human diploid fibroblasts. Oncogene 8:1887-1893.
50. Shay, J. W., W. E. Wright, D. Brasiskyte, and B. A. Van der Hagen. 1993. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalisation in human mammary epithelial cells but not human fibroblasts. Oncogene 8:1407-1413.
51. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G (1) cyclin-dependent kinases. Genes Dev. 9:1149-1163.
52. Sherwood, S. W., D. Rush, J. L. Ellsworth, and R. T. Schimke. 1988. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc. Natl. Acad. Sci. USA 85:9086-9090.
53. Small, M. B., Y. Gluzman, and H. L. Ozer. 1982. Enhanced transformation of human fibroblasts by origin-defective simian virus 40. Nature 296:671-672.
54. Smith, J. R., and O. M. Pereira-Smith. 1996. Replicative senescence: implications for in vivo aging and tumour suppression. Science 273:63-67.
55. Stein, G. H., M. Beeson, and L. Gordon. 1990. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249: 666-669.
56. Stephen, C. W., P. Helminen, and D. P. Lane. 1995. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. J. Mol. Biol. 248:58-78.
57. sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10:835-840.
58. Vojta, P. J., and J. C. Barrett. 1995. Genetic analysis of cellular senescence. Biochim. Biophys. Acta 1242:29-41.
59. Vojtesek, B., J. Bartek, C. A. Midgley, and D. P. Lane. 1992. An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immunol. Methods 151:237-244.
60. Wazer, D. E., X.-L. Liu, Q. Chu, Q. Gao, and V. Band. 1995. Immortalization of distinct human mammary epithelial cell types by human papillomavirus 16 E6 or E7. Proc. Natl. Acad. Sci. USA 92:3687-3691.
61. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
62. Wynford-Thomas, D. 1996. p53: guardian of cellular senescence. J. Pathol. 180:118-121.
63. Wynford-Thomas, D. 1997. Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology. Eur. J. Cancer 33:716-725.
64. Wynford-Thomas, D., C. J. Jones, and F. S. Wyllie. 1996. The tumour suppressor gene p53 as a regulator of proliferative life-span and tumour progression. Biol. Signals 5:139-153.
65. Yan, Y., M. M. Ouellette, J. W. Shay, and W. E. Wright. 1996. Age-dependent alterations of c-fos and growth regulation in human fibroblasts expressing the HPV16 E6 protein. Mol. Biol. Cell 7:975-983.